1. The FDA approved Teva Pharmaceutical’s generic version of Sabril or vigabatrin tablets, which are used to treat complex partial seizures in patients 10 years and older. This is the first generic version of the tablets.
2. Cabometyx is now an approved treatment for patients with hepatocellular carcinoma who have been treated previously with sorafenib.
3. Amplatzer Piccolo Occluder is a medical device that can be implanted into a patient to treat a congenital heart defect called patent ductus arteriosus. The device can be used on premature babies.
4. The FDA approved the expanded use of Adacel, Sanofi’s diphtheria, pertussis and tetanus vaccine, to include a repeat vaccination against the three illnesses.
More articles on supply chain:
Medline to build healthcare supply chain center, create up to 400 jobs
3 New Year’s resolutions to kick-start your supply chain in 2019
Red Cross issues urgent call for blood donors
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
